Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents

Therapeutics with novel modes of action and a low risk of generating resistance are urgently needed to combat drug-resistant Plasmodium falciparum malaria. Here, we report that the peptide vinyl sulfones WLL-vs (WLL) and WLW-vs (WLW), highly selective covalent inhibitors of the P. falciparum proteas...

Descripción completa

Detalles Bibliográficos
Autores principales: Stokes, Barbara H., Yoo, Euna, Murithi, James M., Luth, Madeline R., Afanasyev, Pavel, da Fonseca, Paula C. A., Winzeler, Elizabeth A., Ng, Caroline L., Bogyo, Matthew, Fidock, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553790/
https://www.ncbi.nlm.nih.gov/pubmed/31170268
http://dx.doi.org/10.1371/journal.ppat.1007722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553790/
https://www.ncbi.nlm.nih.gov/pubmed/31170268
http://dx.doi.org/10.1371/journal.ppat.1007722

Ejemplares similares